WEX Pharmaceuticals Inc. is a late-stage drug development\\r\\ncompany in Vancouver, Canada dedicated to the research, development,\\r\\nmanufacture, and commercialization of Halneuron®, a novel non-opioid analgesic.
\\r\\n\\r\\nHalneuron® is a highly selective sodium channel blocker\\r\\nand represents a breakthrough in painkiller technology: Non-addictive, no\\r\\nwithdrawal symptoms and no euphoria; no build of up of tolerance over time; a\\r\\nlong duration of pain relief with minimal side effects; safe for human use and\\r\\ntested in over 600 people to date. Halneuron’s active pharmaceutical ingredient\\r\\nis Tetrodotoxin (TTX), a small molecule known to block voltage-gated sodium\\r\\nchannels on neurons and prevents pain by inhibiting the initiation and\\r\\nconduction of nerve impulses in the peripheral nervous system which is\\r\\nassociated with